PT  - JOURNAL ARTICLE
AU  - Marcelo Wolff
AU  - Margarita Gilabert
AU  - Rodrigo Hernández
TI  - Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults
AID  - 10.1101/2022.02.07.22270555
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.07.22270555
4099  - http://medrxiv.org/content/early/2022/02/08/2022.02.07.22270555.short
4100  - http://medrxiv.org/content/early/2022/02/08/2022.02.07.22270555.full
AB  - Summary The inactivated SARS-CoV-2 vaccine (CoronaVac®) has been the principal vaccine used in Chile’s pre-booster immunization campaign. We compared major outcomes in 260 hospitalized vaccinated vs 507 unvaccinated adults with COVID-19 (mid-2021). The vaccinated group was much older, required less critical care, had lower hospital mortality (adjusted by age), and had shorter hospitalization than the unvaccinated. Benefits were most pronounced in those older than 59 yearsObjective To compare major outcomes in fully vaccinated and unvaccinated adult persons hospitalized for COVID-19 in a general private hospital in Santiago, Chile during mid2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee (for clinical investigation) of Clinica Santa Maria gave ethical approval for this work and waived the requirement for individual informed consentI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used for this work is embedded in a authorized institutional database especific for COVID-19 hospitalized patients in the institution, only accessible upon authorization